Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Desorex 75microgram tablets
0703021Q0BFAAAA
|
Desorex | Desogestrel | Obstetrics, Gynaecology and Urinary-Tract Disorders | 2,632 |
|
Lidocaine 4% cream
1502010I0AAAKAK
|
Lidocaine (Local Anaesthesia) | Lidocaine | Anaesthesia | 2,628 |
|
Galfer 140mg/5ml syrup
0901011F0BDABAI
|
Galfer | Ferrous fumarate | Nutrition and Blood | 2,625 |
|
Hydrocortisone 2.5% cream
1304000V0AAAFAF
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | 2,624 |
|
Ugo sterile catheter valve
22056150501
|
Ugo sterile catheter valve | Catheter Valves | Incontinence Appliances | 2,624 |
|
Gelclair concentrated oral gel 15ml sachets
21190000001
|
Gelclair concentrated oral gel 15ml sachets | Oral Film Forming Agents | Appliances | 2,622 |
|
Ciclesonide 80micrograms/dose inhaler CFC free
0302000U0AAAAAA
|
Ciclesonide | Ciclesonide | Respiratory System | 2,615 |
|
Instant Carobel powder
0913161A0BGAAAG
|
Instant Carobel powder thickener - gum based | Powder thickener - gum based (0913161) | Nutrition and Blood | 2,614 |
|
Aymes Shake Compact powder 57g sachets chocolate
0913011F0BBABAA
|
Aymes powder 2.3 - 2.4 kcal/ml milkshake lower volume | Powder 2.3 - 2.4 kcal/ml milkshake lower volume (0913011) | Nutrition and Blood | 2,611 |
|
Sertraline 50mg/5ml oral suspension
0403030Q0AAAQAQ
|
Sertraline hydrochloride | Sertraline hydrochloride | Central Nervous System | 2,610 |
|
PF Drops Carmellose 1% eye drops preservative free
21300000154
|
PF Drops Carmellose 1% eye drops preservative free | Eye Products | Appliances | 2,609 |
|
Coal tar solution 5% cutaneous emulsion
1305020C0AACXCX
|
Coal tar/tar (Topical) | Tars | Skin | 2,607 |
|
Zetuvit Plus Superabsorber dressing 20cm x 25cm
20031700310
|
Zetuvit Plus Superabsorber dressing 20cm x 25cm | Wound Management & Other Dressings | Dressings | 2,607 |
|
Hypromellose 0.32% eye dps 0.5ml unit dose preservative free
1108010F0AABSBS
|
Hypromellose | Hypromellose | Eye | 2,604 |
|
Microdot Plus lancets 0.3mm/30gauge
21010900910
|
Microdot Plus lancets 0.3mm/30gauge | Other Appliances | Appliances | 2,602 |
|
Calcium carbonate 500mg chewable tablets
0101021C0AAAFAF
|
Calcium carbonate (Antacid) | Calcium carbonate | Gastro-Intestinal System | 2,601 |
|
Microdot Max Safety Pen hypod ins needles for pre-filled/reusable pen injectors screw on 5mm/30gauge
21010900921
|
Microdot Max Safety Pen hypod ins needles for pre-filled/reusable pen injectors screw on 5mm/30gauge | Other Appliances | Appliances | 2,600 |
|
Fresubin Protein Energy drink (5 flavours)
0913011K0BEAAAD
|
Fresubin RtS 1.5 - 1.6 kcal/ml milkshake higher protein | RtS 1.5 - 1.6 kcal/ml milkshake higher protein (0913011) | Nutrition and Blood | 2,598 |
|
Lorazepam 1mg/ml oral solution sugar free
0401020P0AACICI
|
Lorazepam | Lorazepam | Central Nervous System | 2,595 |
|
Ensure liquid (2 flavours)
0913011I0BBAAAC
|
Ensure ready to serve 1 - 1.3 kcal/ml m/sk lower energy | Ready to serve 1 - 1.3 kcal/ml m/sk lower energy (0913011) | Nutrition and Blood | 2,589 |
|
Dioctyl 100mg capsules
0106020I0BBAGAK
|
Dioctyl (Systemic) | Docusate sodium | Gastro-Intestinal System | 2,588 |
|
Insulin detemir 100units/ml inj 3ml pf dispos dev
0601012X0AAABAB
|
Insulin detemir | Insulin detemir | Endocrine System | 2,588 |
|
Pentasa 4g modified-release granules sachets
0105010B0BCAHBA
|
Pentasa | Mesalazine (Systemic) | Gastro-Intestinal System | 2,585 |
|
Ibugel 5% gel
1003020P0BDAAAC
|
Ibugel | Ibuprofen | Musculoskeletal and Joint Diseases | 2,579 |
|
Kaltostat dressing 5cm x 5cm
20030200030
|
Kaltostat dressing 5cm x 5cm | Wound Management & Other Dressings | Dressings | 2,579 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.